About metabolism of a carcinoma cell

Most cancer cells utilize aerobic glycolysis irrespective of their tissue of origin. The alteration from oxidative phosphorylation to glycolysis – called the Warburg effect – is an universal phenomen and has now become a diagnostic tool for cancer detection. Warburg O, Posener K, Negelein E.

[ read more ]

Variation in cancer risk among tissues can be explained by the number of stem cell divisions

Tomasetti and Vogelstein show that the lifetime risk of cancers of many different types is strongly correlated with the total number of divisions of the normal self-renewing cells maintaining that tissue’s homeostasis. These results suggest that only a third of the variation in cancer risk among t

[ read more ]

Quantum Teleportation and Von Neumann Entropy

From the aspect of the quantum information theories, various quantum entropies are possibly computed at each stage, which ensures the emergence of the entangled states in the intermediate step. If a single qubit quantum teleportation is near the computational basis, the quantum measurement is domina

[ read more ]

A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine

Progressive increase in mtDNA 3243A>G heteroplasmy causes abrupt transcriptional reprogramming Wallace hypothesized mitochondrial dysfunction as a central role in a wide range of age-related disorders and various forms of cancer. Steadily rising increases in mitochondrial DNA mutations cause abr

[ read more ]

Implications of quantum metabolism and natural selection for the origin of cancer cells and tumor progression

Energy transfer in material solids is driven primarily by differences in intensive thermodynamic quantities such as pressure and temperature. The crucial observation  in quantum-theoretical models was the consideration of the heat capacity as associated with the vibrations of atoms in a crystalline

[ read more ]

Wholeness and implicate order: “Deep” quantum chemistry and cell consciousness: quantum chemistry controls genes and biochemistry to give cells and higher organism’s consciousness and complex behavior

Bohm used the term ‘holomovement’ which is an unbroken and undivided totality and carries an implicate order which is he totality of an order including both the manifested and non-manifested aspects of the order. Non-local quantum phenomena reside in a subtler level than quantum level that is th

[ read more ]

Quantum Tunnelling to the Origin and Evolution of Life

Quantum tunnelling is a phenomenon which becomes relevant at the nanoscale and below. It is a paradox from the classical point of view as it enables elementary particles and atoms to permeate an energetic barrier without the need for sufficient energy to overcome it. Tunnelling is being of vital imp

[ read more ]

Quantum entanglement between the electron clouds of nucleic acids in DNA

Rieper, Anders and Vedral modelled the electron clouds of nucleic acids in a single strand of DNA as a chain of coupled quantum harmonic oscillators with dipole-dipole interaction between nearest neighbours. As a main result, the entanglement contained in the chain coincides with the binding energy

[ read more ]

A new theory of the origin of cancer: quantum coherent entanglement, centrioles, mitosis, and differentiation

Low non-specific, low intensity laser illumination (635, 670 or 830 nm) apparently enhances centriole replication and promotes cell division, what is the opposite of a desired cancer therapy. In the contrary, centrioles are sensitive to coherent light. Then higher intensity laser illumination - stil

[ read more ]

Mitochondria and the evolutionary roots of cancer

Cancer is a group of almost 200 diseases that involve variety of changes in cell structure, morphology, and physiology. Cancer phenotype is underlying several alterations in cellular dynamics with three most critical features, which includes self-sufficiency in growth signals and insensitivity to in

[ read more ]

A global assessment of cancer genomic alterations in epigenetic mechanisms

Muhammad A Shah, Emily L Denton, Cheryl H Arrowsmith, Mathieu Lupien and Matthieu Schapira

Abstract

Background

The notion that epigenetic mechanisms may be central to cancer initiation and progression is supported by recent next-generation sequencing efforts revealing that genes involved in chromatin-mediated signaling are recurrently mutated in cancer patients.

Results

Here, we analyze mutational and transcriptional profiles from TCGA and the ICGC across a collection 441 chromatin factors and histones. Chromatin factors essential for rapid replication are frequently overexpressed, and those that maintain genome stability frequently mutated. We identify novel mutation hotspots such as K36M in histone H3.1, and uncover a general trend in which transcriptional profiles and somatic mutations in tumor samples favor increased transcriptionally repressive histone methylation, and defective chromatin remodeling.

Conclusions

This unbiased approach confirms previously published data, uncovers novel cancer-associated aberrations targeting epigenetic mechanisms, and justifies continued monitoring of chromatin-related alterations as a class, as more cancer types and distinct cancer stages are represented in cancer genomics data repositories.

Continue reading A global assessment of cancer genomic alterations in epigenetic mechanisms

Three-dimensional super-resolution microscopy of the inactive X chromosome territory reveals a collapse of its active nuclear compartment harboring distinct Xist RNA foci

3D-SIM-based DAPI intensity classification in the Barr body versus the entire nucleus of C2C12 cells. (A) Mid z-section of a DAPI-stained nucleus. The area below the dashed line illustrates the resolution level obtained by wide-field deconvolution microscopy, for comparison. Inset magnifications show the non-uniformly compacted structure of the Barr body resolvable with 3D-SIM (1) and an arbitrary autosomal region with CDCs (2). Scale bars: 5 μm, insets 1 μm. (B) X chromosome-specific painting (green) of Xi (left) and Xa territories (right) of the same nucleus in different z-sections. Note the high convergence between the painted Xi and the DAPI visualized Barr body (arrowheads). Scale bars: 2 μm, insets 1 μm. (C) 3D DAPI intensity classification exemplified for the nucleus shown in (A). Seven DAPI intensity classes displayed in false-color code ranging from class 1 (blue) representing pixels close to background intensity, largely representing the IC, up to class 7 (white) representing pixels with highest density, mainly associated with chromocenters. Framed areas of the Barr body (inset 1) and a representative autosomal region (inset 2) are shown on the right at resolution levels of 3D-SIM, deconvolution and conventional wide-field microscopy. The Xi territory pervaded by lower DAPI intensities becomes evident only at 3D-SIM resolution, whereas both wide-field and deconvolution microscopy imply a concentric increase of density in the Barr body. In the autosomal region, chromatin assigned to classes 2 to 3 lines compacted CDCs, represented by classes 4 to 6. (D) Left: average DAPI intensity classification profiles with standard deviations evaluated for entire nuclear volumes or the Barr body region only (dark grey bars). Right: over/underrepresentation of the average DAPI intensity class fraction sizes in the Barr body versus entire nuclear volumes (n = 12). Distribution differences on classes between Xi and entire nucleus P <0.001. 3D-SIM, three-dimensional structured illumination microscopy; CDC, chromatin domain cluster; DAPI, 4',6-diamidino-2-phenylindole; FISH, fluorescence in situ hybridization; IC, interchromatin compartment; Xa, active X chromosome; Xi, inactive X chromosome. Smeets et al. Epigenetics & Chromatin 2014 7:8   doi:10.1186/1756-8935-7-8

3D-SIM-based DAPI intensity classification in the Barr body versus the entire nucleus of C2C12 cells. (A) Mid z-section of a DAPI-stained nucleus. The area below the dashed line illustrates the resolution level obtained by wide-field deconvolution microscopy, for comparison. Inset magnifications show the non-uniformly compacted structure of the Barr body resolvable with 3D-SIM (1) and an arbitrary autosomal region with CDCs (2). Scale bars: 5 μm, insets 1 μm. (B) X chromosome-specific painting (green) of Xi (left) and Xa territories (right) of the same nucleus in different z-sections. Note the high convergence between the painted Xi and the DAPI visualized Barr body (arrowheads). Scale bars: 2 μm, insets 1 μm. (C) 3D DAPI intensity classification exemplified for the nucleus shown in (A). Seven DAPI intensity classes displayed in false-color code ranging from class 1 (blue) representing pixels close to background intensity, largely representing the IC, up to class 7 (white) representing pixels with highest density, mainly associated with chromocenters. Framed areas of the Barr body (inset 1) and a representative autosomal region (inset 2) are shown on the right at resolution levels of 3D-SIM, deconvolution and conventional wide-field microscopy. The Xi territory pervaded by lower DAPI intensities becomes evident only at 3D-SIM resolution, whereas both wide-field and deconvolution microscopy imply a concentric increase of density in the Barr body. In the autosomal region, chromatin assigned to classes 2 to 3 lines compacted CDCs, represented by classes 4 to 6. (D) Left: average DAPI intensity classification profiles with standard deviations evaluated for entire nuclear volumes or the Barr body region only (dark grey bars). Right: over/underrepresentation of the average DAPI intensity class fraction sizes in the Barr body versus entire nuclear volumes (n = 12). Distribution differences on classes between Xi and entire nucleus P Smeets et al. Epigenetics & Chromatin 2014 7:8 doi:10.1186/1756-8935-7-8

Daniel Smeets, Yolanda Markaki, Volker J Schmid, Felix Kraus, Anna Tattermusch, Andrea Cerase, Michael Sterr, Susanne Fiedler, Justin Demmerle, Jens Popken, Heinrich Leonhardt, Neil Brockdorff, Thomas Cremer1, Lothar Schermelleh and Marion Cremer

Abstract

Background

A Xist RNA decorated Barr body is the structural hallmark of the compacted inactive X territory in female mammals. Using super-resolution three-dimensional structured illumination microscopy (3D-SIM) and quantitative image analysis, we compared its ultrastructure with active chromosome territories (CTs) in human and mouse somatic cells, and explored the spatio-temporal process of Barr body formation at onset of inactivation in early differentiating mouse embryonic stem cells (ESCs).

Results

We demonstrate that all CTs are composed of structurally linked chromatin domain clusters (CDCs). In active CTs the periphery of CDCs harbors low-density chromatin enriched with transcriptionally competent markers, called the perichromatin region (PR). The PR borders on a contiguous channel system, the interchromatin compartment (IC), which starts at nuclear pores and pervades CTs. We propose that the PR and macromolecular complexes in IC channels together form the transcriptionally permissive active nuclear compartment (ANC). The Barr body differs from active CTs by a partially collapsed ANC with CDCs coming significantly closer together, although a rudimentary IC channel system connected to nuclear pores is maintained. Distinct Xist RNA foci, closely adjacent to the nuclear matrix scaffold attachment factor-A (SAF-A) localize throughout Xi along the rudimentary ANC. In early differentiating ESCs initial Xist RNA spreading precedes Barr body formation, which occurs concurrent with the subsequent exclusion of RNA polymerase II (RNAP II). Induction of a transgenic autosomal Xist RNA in a male ESC triggers the formation of an ‘autosomal Barr body’ with less compacted chromatin and incomplete RNAP II exclusion.

Conclusions

3D-SIM provides experimental evidence for profound differences between the functional architecture of transcriptionally active CTs and the Barr body. Basic structural features of CT organization such as CDCs and IC channels are however still recognized, arguing against a uniform compaction of the Barr body at the nucleosome level. The localization of distinct Xist RNA foci at boundaries of the rudimentary ANC may be considered as snap-shots of a dynamic interaction with silenced genes. Enrichment of SAF-A within Xi territories and its close spatial association with Xist RNA suggests their cooperative function for structural organization of Xi.

Continue reading Three-dimensional super-resolution microscopy of the inactive X chromosome territory reveals a collapse of its active nuclear compartment harboring distinct Xist RNA foci

The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats

Non-neoplastic histopathological findings in the abdominal cavity. A: High-power view of anti-podoplanin immunohistochemistry showing single MWCNT A (high dose) nanotubes in the tissue (arrows). B: High-power view of anti-podoplanin immunohistochemistry showing single asbestos fibers in the tissue (arrows). C: H & E, high-power view of granuloma induced by MWCNT A (low dose) nanotubes including single nanotube (arrow, 25×). D: H & E, high-power view of granuloma induced by asbestos including single fiber (arrow, 40×). Rittinghausen et al. Particle and Fibre Toxicology 2014 11:59   doi:10.1186/s12989-014-0059-z

Non-neoplastic histopathological findings in the abdominal cavity. A: High-power view of anti-podoplanin immunohistochemistry showing single MWCNT A (high dose) nanotubes in the tissue (arrows). B: High-power view of anti-podoplanin immunohistochemistry showing single asbestos fibers in the tissue (arrows). C: H & E, high-power view of granuloma induced by MWCNT A (low dose) nanotubes including single nanotube (arrow, 25×). D: H & E, high-power view of granuloma induced by asbestos including single fiber (arrow, 40×).
Rittinghausen et al. Particle and Fibre Toxicology 2014 11:59 doi:10.1186/s12989-014-0059-z

Susanne Rittinghausen, Anja Hackbarth, Otto Creutzenberg, Heinrich Ernst, Uwe Heinrich, Albrecht Leonhardt and Dirk Schaudien

Abstract

Background

Biological effects of tailor-made multi-walled carbon nanotubes (MWCNTs) without functionalization were investigated in vivo in a two-year carcinogenicity study. In the past, intraperitoneal carcinogenicity studies in rats using biopersistent granular dusts had always been negative, whereas a number of such studies with different asbestos fibers had shown tumor induction. The aim of this study was to identify possible carcinogenic effects of MWCNTs. We compared induced tumors with asbestos-induced mesotheliomas and evaluated their relevance for humans by immunohistochemical methods.

Methods

A total of 500 male Wistar rats (50 per group) were treated once by intraperitoneal injection with 109 or 5 × 109 WHO carbon nanotubes of one of four different MWCNTs suspended in artificial lung medium, which was also used as negative control. Amosite asbestos (108 WHO fibers) served as positive control. Morbid rats were sacrificed and necropsy comprising all organs was performed. Histopathological classification of tumors and, additionally, immunohistochemistry were conducted for podoplanin, pan-cytokeratin, and vimentin to compare induced tumors with malignant mesotheliomas occurring in humans.

Results

Treatments induced tumors in all dose groups, but incidences and times to tumor differed between groups. Most tumors were histologically and immunohistochemically classified as malignant mesotheliomas, revealing a predominantly superficial spread on the serosal surface of the abdominal cavity. Furthermore, most tumors showed invasion of peritoneal organs, especially the diaphragm. All tested MWCNT types caused mesotheliomas. We observed highest frequencies and earliest appearances after treatment with the rather straight MWCNT types A and B. In the MWCNT C groups, first appearances of morbid mesothelioma-bearing rats were only slightly later. Later during the two-year study, we found mesotheliomas also in rats treated with MWCNT D – the most curved type of nanotubes. Malignant mesotheliomas induced by intraperitoneal injection of different MWCNTs and of asbestos were histopathologically and immunohistochemically similar, also compared with mesotheliomas in man, suggesting similar pathogenesis.

Conclusion

We showed a carcinogenic effect for all tested MWCNTs. Besides aspect ratio, curvature seems to be an important parameter influencing the carcinogenicity of MWCNTs.

Continue reading The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats

Forscher des HIPS und des HZI finden neues Antibiotikum gegen gram-negative Bakterien

Biologinnen untersuchen Bakterien unter dem Mikroskop. Foto: Oliver Dietze

Biologinnen untersuchen Bakterien unter dem Mikroskop. Foto: Universität des Saarlandes, Oliver Dietze

Die Erreger von Infektionserkrankungen Escherichia coli, Klebsiella pneumoniae, Acinetobacter baumanii und Pseudomonas aeruginosa haben zwei große Gemeinsamkeiten: Sie gehören zu den sogenannten gram-negativen Bakterien und sind in Krankenhäusern besonders gefürchtet. Wissenschaftler des Helmholtz-Instituts für Pharmazeutische Forschung Saarland (HIPS) und des Helmholtz-Zentrums für Infektionsforschung (HZI) in Braunschweig haben nun ein potenzielles neues Antibiotikum entdeckt, das gegen diese schwer zu bekämpfenden Bakterien wirkt. Ihre Ergebnisse veröffentlichten die Forscher im renommierten Journal Angewandte Chemie International Edition.

Immer mehr Keime entwickeln Resistenzen gegen Antibiotika, sodass diese einstigen Wunderwaffen ihre Wirkungskraft verlieren. Vor allem in Krankenhäusern stellt die steigende Anzahl resistenter Keime das Personal vor große Probleme und ist eine große Gefahr für die Patienten. „Am schwierigsten zu behandeln ist die Gruppe der gram-negativen Bakterien. Diese besitzen zwei Zellmembranen. Potenzielle Wirkstoffe müssen durch beide hindurch, um eine Wirkung zu erzielen“, sagt Prof. Rolf Müller, Geschäftsführender Direktor des HIPS. Dadurch sind die Anforderungen an mögliche Wirkstoffe wesentlich komplexer als bei den gram-positiven Bakterien, die nur eine Zellmembran besitzen.

Trotz der komplexen Anforderungen ist es Müller und seinen Kollegen aus der Abteilung „Mikrobielle Naturstoffe“ am HIPS und „Mikrobielle Wirkstoffe“ am HZI gelungen, aus dem Myxobakterium Cystobacter sp. einen Stoff zu isolieren, der auch gegen gram-negative Bakterien wirkt. „Wir haben eine aus chemischer Sicht vollkommen neue Stoffklasse entdeckt, die wir Cystobactamide getauft haben“, sagt Müller. „In Experimenten haben wir gezeigt, dass diese gegen die gram-negativen Bakterien Escherichia coli und Acinetobacter baumannii wirksam sind.“ Die Wirkstoffe sind also in der Lage, die doppelte Zellmembran zu durchdringen und die Bakterien so bekämpfen.

Auch wie sie ihre Wirkung entfalten, konnten die Wissenschaftler bereits zeigen. „Wir konnten nachweisen, dass die Cystobactamide als Gyrasehemmer fungieren: Sie verhindern, dass die DNA der Bakterien platzsparend wie ein verdrillter Gartenschlauch verdichtet werden kann“, erläutert Müller. Wird dieser Vorgang gestört, kann die DNA auch nicht mehr korrekt abgelesen werden, und der Stoffwechsel wird entscheidend behindert.

Gyrasehemmer an sich sind nichts Neues. Ganz im Gegenteil: Viele der bisherigen und wirksamsten Antibiotika basieren auf diesem Prinzip. „Allerdings konnten wir erstmals einen Wirkstoff aus Naturstoffen gewinnen, der so funktioniert“, sagt Müller. Das Potenzial der bekannten, chemisch hergestellten Gyrasehemmer ist praktisch ausgeschöpft. Sie können nach jahrzehntelanger Verbesserung nicht weiterentwickelt werden. In der neuen Stoffklasse der Cystobactamide hingegen gibt es noch vielfältige Optimierungsmöglichkeiten. „Wir hoffen, durch chemische Veränderungen vor allem die Wirkung gegen gram-negative Bakterien weiter verstärken und verbreitern zu können“, erklärt Müller. „Sollte uns das gelingen, sind Cystobactamide ein echter Hoffnungsträger im Kampf gegen Krankenhauskeime und andere gram-negative Bakterien.“

Originalpublikation in Angewandte Chemie International Edition:

Baumann, S., Herrmann, J., Raju, R., Steinmetz, H., Mohr, K. I.,
Hüttel, S., Harmrolfs, K., Stadler, M. and Müller, R. (2014):
„Cystobactamids: Myxobacterial Topoisomerase Inhibitors Exhibiting
Potent Antibacterial Activity“. DOI: 10.1002/anie.201409964
<http://onlinelibrary.wiley.com/doi/10.1002/anie.201409964/full>

Schlaganfall-Patient kann dank neuartiger Therapie wieder räumlich sehen

Das Bild zeigt eine Fusions-Diagnostik: Die Probandin trägt eine Bagolini-Brille. Die Therapeutin hält ihr ein Prisma vor ein Auge und misst dabei ihre Fusion, das heißt, sie ermittelt, inwieweit sie in der Lage ist, die Bilder beider Augen zusammenzuführen. Foto: Oliver Dietze

Das Bild zeigt eine Fusions-Diagnostik: Die Probandin trägt eine Bagolini-Brille. Die Therapeutin hält ihr ein Prisma vor ein Auge und misst dabei ihre Fusion, das heißt, sie ermittelt, inwieweit sie in der Lage ist, die Bilder beider Augen zusammenzuführen. Foto: Universität des Saarlandes, Oliver Dietze

Sehstörungen zählen mit zu den häufigsten Folgen eines Schlaganfalls. In seltenen Fällen tritt dabei der Verlust des räumlichen Sehens ein. Die Patienten nehmen die Welt um sich herum nur noch flach wie ein Bild wahr. Sie können keine Entfernungen mehr abschätzen, etwa wenn sie nach einer Tasse greifen oder sich ihnen auf der Straße ein Auto nähert. Diese Störung haben Forscher aus Saarbrücken um Professor Georg Kerkhoff und Anna-Katharina Schaadt mit Kollegen der Charité – Universitätsmedizin Berlin bei einem Patienten genauer untersucht. Sie haben nun erstmals ein wirksames Behandlungskonzept entwickelt und nachgewiesen, welches Hirnareal für diese Sehstörung verantwortlich ist. Die Studie wurde in der renommierten Fachzeitschrift „Neuropsychologia“ veröffentlicht.

Nach einem Schlaganfall kann es zu unterschiedlichen Formen von Sehstörungen kommen. „Diese äußern sich etwa darin, dass die Patienten auf einer Seite blind sind, sodass sie Hindernisse oder Personen auf der Seite übersehen oder Probleme beim Lesen haben“, erklärt Georg Kerkhoff, Professor für Klinische Neuropsychologie der Saar-Uni und Leiter der Neuropsychologischen Universitätsambulanz. Manchmal sind die Folgen aber weitaus gravierender: So hat das Team um Kerkhoff und Schaadt zusammen mit Forscherkollegen um Neurologie-Professor Dr. Stephan Brandt und Dr. Antje Kraft von der Charité in Berlin einen Patienten betreut, bei dem es in Folge eines Schlaganfalls zum Verlust des räumlichen Sehens gekommen war. Zwar konnte er alle Details in seiner Umgebung wahrnehmen, er war allerdings nicht mehr in der Lage, Entfernungen richtig einzuschätzen. „Für ihn war alles flach wie auf einem Gemälde“, erklärt Anna-Katharina Schaadt, Doktorandin bei Kerkhoff und Erstautorin der Studie. „Er bewegte sich daher wie in Zeitlupe und war stets unsicher, wie weit zum Beispiel eine Kaffeetasse auf dem Tisch entfernt ist oder wie schnell sich ein heranfahrendes Auto nähert.“ Wie ein Blinder habe er daher einen langen Stock genutzt, um sich in seiner Umgebung zu orientieren.

In der Neuropsychologischen Hochschulambulanz auf dem Saarbrücker Campus haben die Wissenschaftler um Kerkhoff und Schaadt zunächst die Ursache für diese Störung gesucht. „Wir haben herausgefunden, dass der Patient die Seheindrücke seiner beiden Augen nicht mehr zu einem Gesamtbild verschmelzen konnte“, sagt Schaadt. Fachleute bezeichnen diesen Prozess bei gesunden Menschen als binokulare Fusion. Sie ist wichtig für das dreidimensionale Sehen.

Nach der Diagnose haben die Psychologen im Rahmen einer Therapie über drei Wochen hinweg täglich das räumliche Sehen des Patienten geschult. Dabei kamen drei verschiedene Verfahren zum Einsatz: Mit speziellen optischen Trainingsgeräten (Prismen, Vergenztrainer und Cheiroskop) wurden dem Patienten zwei seitlich leicht versetzte Bilder präsentiert. Diese sollten mit Hilfe sogenannter konvergenter Augenbewegungen zu einem einzigen Bild zusammengesetzt werden. Bei diesem Prozess bewegen sich die Augen gegensinnig zur Nase hin, während die Bilder aber im Blickfeld bleiben. Mit der Zeit „verschmelzen“ die beiden zu einem Bild, das auch räumliche (stereoskopische) Tiefe enthält. „Für den Betroffenen war es so, als ob jemand einen Schalter umgelegt hat. Plötzlich konnte er wieder räumlich sehen, Entfernungen richtig einschätzen und Gegenstände zielsicher greifen“, schildert Schaadt die Eindrücke des Patienten, der mittlerweile wieder seinem Beruf als Jurist nachgehen kann. Auch ein Jahr später in einer Nachuntersuchung konnte der Patient weiterhin räumlich sehen, sodass er laut Kerkhoff als dauerhaft geheilt gilt.

Mit dem Verfahren könnten Therapeuten künftig auch anderen Schlaganfall-Patienten helfen, diese extreme Form der Sehstörung zu behandeln. Zudem sind die Ergebnisse für die Forschung interessant, wie Professor Brandt erläutert: „Sie zeigen, wie spezifisch unser Gehirn organisiert ist. Das geschädigte Areal im sogenannten Parietallappen V6/V6A ist auf 3D-Sehen spezialisiert. Aus Studien an Primaten ist die Hirnregion bereits bekannt. Ihre Funktion beim Menschen ist aber noch nicht hinreichend erforscht.“

Die Studie ist erschienen unter:

Schaadt, A.K., Brandt, S.A., Kraft, A., Kerkhoff, G. Holmes and Horrax
(1919) revisited: Impaired binocular fusion as a cause of “flat
vision” after right parietal brain damage – A case study.
Neuropsychologia (2015), DOI:10.1016/j.neuropsychologia.2015.01.029

 

Cancer news

Similarities between next-generation prostate cancer drugs discovered

22. Jun. 2017

For the first time, researchers have shown how a class of advanced prostate cancer drugs are processed in the body and how their anti-tumor activity might change depending on how they are metabolized. Their pre-clinical findings may lay the foundation for improving therapies for treatment-resistant, aggressive prostate cancer. (Mehr in: Cancer News — ScienceDaily)

- Read more

Better use of current drugs to target cancer

22. Jun. 2017

Researchers worked backwards, employing a series of drugs used in the clinic to understand a new way that cancer stem cells can be killed. (Mehr in: Cancer News — ScienceDaily)

- Read more

An enzyme to synthetize carbohydrates designed

22. Jun. 2017

Sugar or carbohydrate synthesis is important for the development of diagnostic tests, vaccines and new drugs. In a study, researchers have synthesized carbohydrates with enzymes through a reaction that was not much studied so far on these biomolecules and which creates few by-products. (Mehr in: Cancer News — ScienceDaily)

- Read more

Flipping the switch to stop tumor development

22. Jun. 2017

Researchers show how a protein prevents the uncontrolled expansion of immune cells, and have outlined their findings in a new report. (Mehr in: Cancer News — ScienceDaily)

- Read more

Secondhand smoke exposure among nonsmoking adult cancer survivors has declined

22. Jun. 2017

From 1999/2000 to 2011/2012, exposure to secondhand smoke among nonsmoking adult cancer survivors declined from 39.6 percent to 15.7 percent, but rates of exposure were higher among those with a history of a smoking-related cancer and those living below the federal poverty level compared with those with other types of cancer and those with the highest incomes, respectively. (Mehr in: Cancer News — ScienceDaily)

- Read more

First-line immunotherapy treatment can improve survival for subset of lung cancer patients

22. Jun. 2017

Findings from a phase III clinical trial for advanced lung cancer patients could help oncologists better predict which patients are likely to receive the most benefit from immunotherapy as a first-line treatment based on the unique molecular characteristics of their tumor, according to a new study. (Mehr in: Cancer News — ScienceDaily)

- Read more

‚Rosetta Stone‘ to decode immune recognition

21. Jun. 2017

Medical researchers have developed an algorithm that predicts T cell recognition of antigens and sets the stage to more effectively harness the immune system. (Mehr in: Cancer News — ScienceDaily)

- Read more

Underused cancer test could improve treatment for thousands

21. Jun. 2017

A simple blood test could improve treatment for more than 1 in 6 stage 2 colon cancer patients, suggests new research. The researchers also discovered that many patients who could benefit from the test likely aren’t receiving it. (Mehr in: Cancer News — ScienceDaily)

- Read more

New antibody uses 1-2 punch to potentially treat blood cancers

21. Jun. 2017

Researchers have developed a two-pronged approach to blood cancer treatment: 1) attacking cancer cells directly and/or 2) driving them from the nurturing bone marrow environment into the peripheral blood streams, where they are more vulnerable (for example, to chemotherapy). (Mehr in: Cancer News — ScienceDaily)

- Read more

New inhibitor drug shows promise in relapsed leukemia

21. Jun. 2017

A new drug shows promise in its ability to target one of the most common and sinister mutations of acute myeloid leukemia (AML), according to researchers. In a first-in-human study, researchers treated relapsed patients with gilteritinib, an FLT3 inhibitor, and found it was a well-tolerated drug that led to frequent and more-sustained-than-expected clinical responses, almost exclusively in patients with this mutation. (Mehr in: Cancer News — ScienceDaily)

- Read more

New sensors could enable more affordable detection of pollution, diseases

21. Jun. 2017

When it comes to testing for cancer, environmental pollution and food contaminants, traditional sensors can help. The challenges are that they often are bulky, expensive, non-intuitive and complicated. Now, one team reports that portable pressure-based detectors coupled with smartphone software could provide a simpler, more affordable alternative while still maintaining sensitivity. (Mehr in: Cancer News — ScienceDaily)

- Read more

Finding the perfect match: New approach to battle drug-resistant bacteria

20. Jun. 2017

Antibiotics were the wonder drug of the 20th century, but bacteria evolved resistance. According to the CDC, more than 2 million people in the U.S. develop MDR infections every year. Researchers have now developed a rapid screen to pair existing FDA-approved drugs to combat MDR infections. (Mehr in: Cancer News — ScienceDaily)

- Read more

Family history and location of genetic fault affect risk for carriers of cancer genes

20. Jun. 2017

A large scale study of women carrying faults in important cancer genes should enable doctors to provide better advice and counselling for treatments and lifestyle changes aimed at reducing this risk. (Mehr in: Cancer News — ScienceDaily)

- Read more

Age-specific overall risk of breast, ovarian cancer among women with BRCA1/2 genetic mutations

20. Jun. 2017

Researchers conducted an analysis that included nearly 10,000 women with the BRCA1 or BRCA2 genetic mutations to estimate the age-specific risk of breast or ovarian cancer for women with these mutations, according to a study. (Mehr in: Cancer News — ScienceDaily)

- Read more

Brain tumors: Still devastating, but treatment has come a long way

20. Jun. 2017

A neurosurgeon discusses advances in brain tumor diagnosis and treatment that are bringing renewed hope to the battle against brain cancer. (Mehr in: Cancer News — ScienceDaily)

- Read more

How cells combat chromosome imbalance

20. Jun. 2017

Biologists have now identified a mechanism that the immune system uses to eliminate genetically imbalanced cells from the body. (Mehr in: Cancer News — ScienceDaily)

- Read more

Combining immunotherapies effective against mouse model of cancer

19. Jun. 2017

A recent study points to a new treatment strategy for rhabdomyosarcoma that takes advantage of the body’s own immune response. (Mehr in: Cancer News — ScienceDaily)

- Read more

Veranstaltungen

Art / Nature:Contemporary Art in Natural History Museums and Collections

02. Jun. 2017

A pilot project in cooperation with the German Federal Cultural Foundation.

The conference outlines recent and ongoing art projects and art programmes in natural history museums and in the natural history collections of multidisciplinary museums. In doing so, it aims to reflect upon and discuss the expectations, potentials, possible limitations and values of these kinds of interactions and interventions from the perspectives of curators, artists and researchers. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

8th Mildred Scheel Cancer Conference

02. Jun. 2017

Zum 8. Mal lädt die Deutsche Krebshilfe, gemeinsam mit der Deutschen Krebsgesellschaft, zur Mildred Scheel Cancer Conference ein. Vom 14.-16. Juni 2017 treffen sich renommierte Krebsexperten in Bonn, um über aktuelle Entwicklungen auf dem Gebiet der onkologischen Forschung zu diskutieren. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

8th International Triticeae Symposium 2017

02. Jun. 2017

This symposium includes four main themes:

Taxonomy, Phylogeny and Phytogeography Biodiversity and Conservation Genetics and Genomics Breeding and Utilization (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

8. Bayerischer Fachkongress Glücksspiel

02. Jun. 2017

Am 28. Juni 2017 findet der 8. Bayerische Fachkongress Glücksspiel im Novotel München City statt. Der Kongress läuft dieses Jahr unter dem Motto Migration – Trauma – Glücksspiel (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

7. HIPS Symposium on pharmaceutical sciences devoted to infection research

02. Jun. 2017

The HIPS symposium brings together renowed scientists and young investigators from three pharmaceutical communities: natural products, medicinal chemistry and drug delivery. It provides a forum for scientists to exchange ideas while crossing boundaries of classical disciplines. At the same time it gives young investigators the opportunity to obtain valuable feedback on their projects by international experts in the respective fields. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

3. Zukunftskongress "Technik zum Menschen bringen"

02. Jun. 2017

Der 3. Zukunftskongress „Technik zum Menschen bringen“ des Bundesministeriums für Bildung und Forschung findet vom 26. bis 27. Juni in Bonn (World Conference Center Bonn) statt. Diskutieren Sie mit uns gemeinsam neue Trends und informieren Sie sich über laufende und künftige Fördermaßnahmen des BMBF. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen

37. Jahestagung Deutsche Gesellschaft für Senologie e.V.

02. Jun. 2017

Zur diesjährigen Jahrestagung der Deutschen Gesellschaft für Senologie e. V. (DGS) vom 29. Juni bis 1. Juli 2017 im CityCube Berlin werden wieder über 2500 Experten für Brusterkrankungen erwartet. Alle Experteninnen und Experten der verschiedenen Fachdisziplinen, die die Senologie vereint diskutieren auf den ca. 170 wissenschaftlichen Sitzungen, Kursen und Debatten gemeinsam über aktuelle Fragestellungen zur Früherkennung, Diagnostik, Therapie und Nachsorge von Brusterkrankungen. (Mehr in: Veranstaltungen – idw – Informationsdienst Wissenschaft)

- Weiterlesen